High prevalence of Merkel cell polyomavirus is associated with dysregulation in transcript levels of TLR9 and type I IFNs in a large cohort of CF patients from the Italian (Lazio) reference center for cystic fibrosis.


Journal

Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 03 03 2022
revised: 14 04 2022
accepted: 13 06 2022
pubmed: 26 6 2022
medline: 10 8 2022
entrez: 25 6 2022
Statut: ppublish

Résumé

Merkel cell polyomavirus (MCPyV) has been detected in respiratory specimens including those from Cystic Fibrosis (CF) patients, raising questions about its immunological and clinical relevance in the respiratory tract. MCPyV might promote an inappropriate antiviral response contributing to a chronic inflammatory response and resulting in detrimental effects in CF. Respiratory samples (n = 1138) were randomly collected from respiratory tract of CF patients (n = 539) during July 2018-October 2019. MCPyV-DNA detection was performed by real time PCR and positive samples were characterized by sequencing of the NCCR genomic region. The transcript levels of Toll-like receptor 9 (TLR9) and type I interferon (IFN-I) genes (IFNα, IFNβ and IFNε) were examined by real-time RT-PCR assays. MCPyV-DNA was detected in 268 out of 1138 respiratory specimens (23.5%) without any difference in the prevalence of MCPyV-DNA according to age, gender or bacteriological status of CF individuals. Thirteen out of 137 CF patients remained positive for MCPyV-DNA over the time (a median follow-up period of 8.8 months). Detection of MCPyV-DNA in respiratory specimens was not associated with the occurrence of exacerbation events. Both MCPyV positive adolescents (11-24 years) and adults (≥25 years) had lower mRNA levels of TLR9, IFNβ, IFNε and IFNα than the negative patients of the same age group, while MCPyV positive children produced increased levels of TLR9 and IFN-I genes (p < 0.05 for TLR9, IFNβ, IFNε) with respect to the negative ones. There were significant differences in TLR9 levels (p < 0.01), but not in those of IFNs, between MCPyV-DNA positive and negative patients with S. aureus, P. aeruginosa or both. Overall, these results indicate that MCPyV-DNA is frequently detected in the respiratory samples of CF patients and might influence the expression levels of IFN-related genes in an age dependent manner. The concomitant detection of MCPyV together with S. aureus and/or P. aeruginosa correlated with alterations in TLR9 levels suggesting that virus-bacteria coinfections might contribute to affect antiviral immunity in CF patients.

Identifiants

pubmed: 35752381
pii: S0882-4010(22)00257-1
doi: 10.1016/j.micpath.2022.105644
pii:
doi:

Substances chimiques

Antiviral Agents 0
DNA, Viral 0
TLR9 protein, human 0
Toll-Like Receptor 9 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105644

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Camilla Bitossi (C)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Agnese Viscido (A)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Carla Prezioso (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy; IRCSS San Raffaele Roma, Microbiology of Chronic Neuro-degenerative Pathologies, 00163, Rome, Italy.

Gabriele Brazzini (G)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.

Maria Trancassini (M)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.

Cristian Borrazzo (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.

Sara Passerini (S)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.

Federica Frasca (F)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Mirko Scordio (M)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Leonardo Sorrentino (L)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Giuseppe Oliveto (G)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Matteo Fracella (M)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Alessandra D'Auria (A)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Carla Selvaggi (C)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Giuseppe Cimino (G)

Lazio Reference Center for Cystic Fibrosis, Policlinico Umberto I University Hospital, 00185, Rome, Italy.

Fabio Midulla (F)

Department of Pediatric Emergency, University La Sapienza of Rome, 00185, Rome, Italy.

Alessandra Pierangeli (A)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy.

Guido Antonelli (G)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy; Microbiology and Virology Unit, Hospital "Policlinico Umberto I", Sapienza University, 00185, Rome, Italy.

Ugo Moens (U)

Department of Medical Biology, Faculty of Health Sciences, University of Tromsø-The Arctic University of Norway, 9037, Tromsø, Norway.

Valeria Pietropaolo (V)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185, Rome, Italy.

Carolina Scagnolari (C)

Laboratory of Virology, Department of Molecular Medicine, Sapienza University of Rome, Affiliated to Istituto Pasteur Italia, 00185, Rome, Italy. Electronic address: carolina.scagnolari@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH